Dr. Daisy Alapat
University of Arkansas, USA

Daisy Alapat is a practising pathologist at the University of Arkansas medical system (UAMS), specialised in Haematopathology with a 15 years of experience. Received medical degree from Odessa state medical university, Ukraine, and trained at the University of Kentucky and Maryland at the department of Pathology. Her major interest focused on clinicopathologic studies of haematopoietic disorders, including plasma cell, lymphoid and myeloid neoplasms and atypical lymphoid proliferations such as EBV-associated disorders and Castleman disease. Currently, she is an associate professor and serves as clinical director of flow cytometry and Co-director of the Haematopathology Section at UAMS.

Dr. Katerina Kamaradova
The Fingerland Department of Pathology
University Hospital Hradec Kralové, Charles University Medical Faculty,
Czech Republic

Graduated from 2nd Medical Faculty of Charles University, Prague, Czech Republic in 2004. Board certified in anatomical pathology since 2009 with more than 15 years of hematopathology experience including consultation practice at academic reference centers. Active member of Czech Lymphoma Study Group including research collaboration.

Dr. Stephen Lade
Peter MacCallum Cancer Centre, Australia

Dr. Lade trained at Melbourne University and has been working as a pathologist at Peter Maccallum Cancer Centre, Melbourne, Australia, since 2002. Peter Maccallum is the oldest comprehensive Cancer Centre in Australia. Dr. Lade's primary area of interest and responsibility is reporting of lymphoid neoplasia including cutaneous lymphomas and other tumour-like lymphoid proliferations. His research is also predominantly in this area.

Dr. Montes Moreno
Marqués de Valdecilla University Hospital, Spain

Dr. Montes Moreno is a pathologist specialised in Haematopathology, Bone & Soft Tissue Pathology and Molecular Diagnosis in Haematopathology and Sarcoma. He is an Assistant Professor at the Universidad de Cantabria and Head of Translational Haematopathology Laboratory at Marqués de Valdecilla (IDIVAL) Research Institute. Dr. Montes Moreno received an extraordinary doctorate award in 2017 for his work in the identification of diagnostic and prognostic markers in aggressive B-cell lymphoma, where his research activity is focused with more than 100 original papers published in peer reviewed journals. He currently lives and works in Santander, Spain.

Dr. Henrique Moura de Paula
Universidade Federal de Goiás, Brazil

Dr de Paula is a Pathologist and Assistant Professor at Faculdade de Medicina da Universidade Federal de Goiás, Brazil. He graduated from Pontificia Universidade Católica de Campinas as a Doctor of Medicine (M.D.) in 2007, before undertaking residencies in Anatomical Pathology at Universidade Federal de São Paulo and Faculdade de Medicina da Universidade de São Paulo. He has co-authored a number of publications over the years, covering the histopathological aspects of Castleman Disease.

Dr. Jadee Neff
Duke University School of Medicine, North Carolina, USA

She completed her residency training in Anatomic and Clinical Pathology and fellowship training in Hematopathology and Molecular Genetic Pathology at Mayo Clinic in Rochester, Minnesota. In addition to her clinical work as a diagnostic Hematopathologist and Molecular Pathologist, she is the Director of the Molecular Genetic Pathology Fellowship Program, the Associate Director of Genomics in the BioRepository and Pathology Research Core, and an Assistant Director of the Molecular, Genetics and Genomics Clinical Laboratory at Duke.

Dr. Grzegorz Rymkiewicz
The Maria Sklodowska-Curie National Research Institute of Oncology, Poland

Dr. Grzegorz Rymkiewicz is an expert haematopathologist. He runs a flow cytometry laboratory with a fine needle aspiration biopsy unit, where he diagnoses approximately 2,500 lymphomas per year by histopathology (HP) with immunohistochemistry (IHC) and flow cytometry (FCM) examinations in conjunction with classical cytogenetic (CC) and molecular results (GEN), currently using next generation sequencing (NGS). In addition, each year he diagnoses about 20 cases of Castleman's disease at the HP level, with a large percentage of HIV positive patients. Dr. Rymkiewicz and his group were the first to publish on Burkitt-like lymphoma with 11q aberration (BLL,11q), without MYC rearrangements, a subtype of lymphoma discovered in 2011 (by using the FNAB/FCM/CC methods) and included in the update of the 2016 WHO classification as a new provisional entity. The discovery of BLL,11q was the culmination of many years of their research into the molecular mechanisms of the development of MYC-negative BL. According to the new 2022 WHO classification of the Haematolymphoid Tumors BLL,11q was renamed as High grade B-cell lymphoma with 11q aberration (HGBL-11q).

Dr. Elena Sabattini
University of Bologna, Italy

Dr. Sabattini is the Chief of the Haematopathology Unit at Bologna University Hospital. She has held a stable position as a pathologist at Bologna University Hospital for 17 years and is also a co-founder of the Haematopathology Group of Italian Society of Pathologic Anatomy and Cytology. Dr. Sabattini is also an active member of the European Association for Haematopathology and European Bone Marrow Working group and has been involved in the organisation of international meetings as past member of the Executive Committee of the European Association for Haematopathology. Dr. Sabattini has authored/ co-authored 227 peer-review papers. Her research interests include lymphoid disorders and myeloproliferative neoplasms.

Dr. Thomas Tousseyn
KU Leuven University, Belgium

Dr. Tousseyn is Professor of Pathology at the KU Leuven University in Belgium. He is Haematopathologist at the University Hospitals Leuven, Belgium, and President of the Belgian Working Group of Haematopathology. He is Executive Committee Member of the European Association for Haematopathology and member of the Castleman Disease Collaborative Network.